LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.


Carclo Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Carclo Plc LSE:CAR London Ordinary Share GB0001751915 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 13.95 1,000 11:34:50
Bid Price Offer Price High Price Low Price Open Price
13.05 14.85
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Steel Wrk, Roll&finish Mill 130.66 5.80 7.90 1.74 10.24
Last Trade Time Trade Type Trade Size Trade Price Currency
11:22:30 O 1,000 14.90 GBX

Carclo (CAR) Latest News

Carclo (CAR) Discussions and Chat

Carclo (CAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Carclo (CAR) Top Chat Posts

Top Posts
Posted at 12/5/2023 13:56 by mesquida
Yes, he has definitely increased, but his previous rns showed a decrease. Can only think that he needed to crystallise a loss before the end of the old tax year and now he has taken advantage of the lower price so as to rebuild his holding to the previous level.
Posted at 20/2/2023 15:22 by mesquida
Chart beginning to turn up, would not be at all surprised if we soon get some news about the compensation package in respect of the cancelled contract. If this news can be wrapped up with confirmation of new banking arrangements then everything is in place to trigger a sizeable rally in the share price.
Posted at 06/1/2023 17:45 by tradertrev
I think this is collateral they are receiving from a dodgy loan to a big stake holder. That is the usual First Equity model. As the value of the collateral falls with the share price, more of the stake holder's holding gets passed across to First Equity. They have no investment interest in Carclo - just a financial transaction for them. I fear this is an overhang.
We have seen this type of loan appear elsewhere, but usually because the stake holder is a director you get full visibility on what's going on. Doesn't appear to be the case here.

Posted at 15/12/2022 12:15 by bombast1
wigwammer - fair enough, but the wider context needs to be considered also. I'd suggest looking at the past history of share purchases by Carclo Directors as a guide
Posted at 15/12/2022 08:38 by dougmachin
I'm not too fussed about CAR, a smaller position that I'm just letting run.

But I think the directors buying shares when they know there's an issue (aka they bought shares after the contraction cancellation announcement), surely this could be seen as a positive.

They're aligning themselves with their shareholders.

And they're using their buying price to say this should be the limit of the downside.

Posted at 13/11/2022 16:54 by tradertrev
I thought First Equity was that company that provide rather dodgy loans to large shareholders in small/mid-caps, who then pledge their holding as security. If the share price falls below a certain level then either more shares need to be pledged or the provider is allowed to sell shares. They usually act as an overhang in the shares of the companies they get involved in.
Can't be sure it's the same First Equity, though.

Posted at 01/7/2022 17:02 by napoleon 14th
A very hard take on CAR by Small Caps Life:
Carclo (CAR.L) - Final Results
On first glance, a company on a P/E of around 8 and growing EPS at 30% looks good value.
However, those who know the history here know that it is a company that got itself in serious trouble and had to sell of one of its largest subsidiaries when it couldn't afford to invest to turn it around. This is a £17m market cap company, but the debt excluding IFRS16 is £21.5m. So a P/E ratio is not a suitable way to value such a business.
Then on top of this is a large pension deficit. The IAS19 deficit has been reducing with higher discount rates:
However, as we know, the IAS19 deficit is largely irrelevant when it comes to the actual payments made by the company. Here they have agreed to £3.5m per year, with the aim to eliminate the deficit within about 20 years!! It is clear that the company is not going to be in a position to pay any dividends to shareholders for about a decade with these debt & pension deficit levels.
The outlook is positive but cautious:
"The Board expects market demand for both the CTP and Aerospace divisions to continue to grow in the next financial year but also that the headwinds that prevailed in the second half will continue during the first half."

Even if we were super generous and assumed a further 30% growth in EPS in FY23, and that the reduced IAS19 deficit was now realistic, then this is on a forward earnings yield of 3.8%. In the current market, there are much better quality companies, with better long-term prospects, that are much less risky and have much higher earnings yields.
Being less generous, given the size of the debt and Pension Deficit, it is still not clear that Carclo's equity has any value at all.
Investegate |Carclo plc Announcements | Carclo plc: Final Results
Investegate announcements from Carclo plc, Final Results

Posted at 04/5/2022 14:58 by 1gw
Oh I’ve been through the wringer, emotionally, on this one, if you're asking. The experience leaves its scars, I think. Just on relatively recent history, starting from part way through the Consort episode:

Optimistic & buying at 116p (23/7/2018)
Hopeful & buying at 11p (31/7/2019)
Optimistic & buying at 18p (24/12/2019)
Depressed & selling at 8p (4/8/20)
Realistic & selling at 19p (26/11/20)
Grateful & selling at 34p (11/3/21)
Ecstatic & selling at 46p (6/5/21)
Since then, I have let the rest ride, hoping for great things but preparing mentally for further disappointments...
1gw - 23 Jul 2018 - 08:45:45 - 945 of 3072
I struggle to see why the share price hasn't gone up more on that announcement. I have managed to pick up a good chunk there at only just over the original mooted price of 116p. Clearly plenty of uncertainty but the fact that Carclo are talking suggests the number must be well over that Doesn't it?
1gw - 31 Jul 2019 - 13:19:33 - 1326 of 3072
I suppose the risk is that they can't sell wipac. But allowing hope to triumph over experience once again with this company, I've bought some more. Certainly brings the average purchase price down.
Duroc must be smarting over their current paper loss and I wonder if they might really want to get their hands on a part of the business to see if they can turn it round. Would there be any serious competition for the asset though?
1gw - 24 Dec 2019 - 10:10:15 - 1471 of 3072
And actually, I've added some just now. Feeling good that the [31st] July purchase worked out so well [so far], and decided to average down a bit more hoping that finally they may have turned a corner.
1gw - 04 Aug 2020 - 17:50:35 - 1678 of 3072
Sold some today.
1gw - 26 Nov 2020 - 14:34:04 - 1924 of 3072
I've taken some off the table there. Too many disappointments in the past with this share to let it all ride into tomorrow's results
1gw - 11 Mar 2021 - 11:37:12 - 2256 of 3072
I did sell some on that spike. Still at a loss vs average purchase price but a good gain working back through the buys
1gw - 06 May 2021 - 15:38:12 - 2396 of 3072
I've just sold some at 46.3p there to celebrate getting back into profit against my average cost of purchase. Didn't think I would see the day...

Posted at 04/5/2022 12:57 by 1gw
Quite an important distinction, isn't it, between a binding bid and an indicative proposal? The indicative proposal was based on public domain information, not Carclo-facilitated due diligence on the actual business. So I struggle to see its relevance to valuing the company today, especially as Carclo no longer has a Wipro business.

Consort announced their 116p indicative proposal just after Carclo had published FY2018 results in which £6.4m underlying operating profit came from the LED technologies business (mainly Wipro), compared to £6.7m from CTP and £0.7m from Aerospace. Underlying operating profit was falling in CTP (£8.7m 2017 down to £6.7m 2018) but rising in LED (£5.9m up to £6.4m). Operating margin was 7% in CTP but 13% in LED.

How much of the 116p proposal do you think was attributed to Wipro?

A more relevant benchmark might come from the Duroc disposal, as they walked away from a 13% stake over 2 years after Consort withdrew, and after Wipro woes became public, but also after the share price had started to recover strongly based on hopes of pandemic-linked business growth. They announced they were out on 26 Feb 2021. Closing price on 25th Feb was 23p.


In terms of current valuation, it is complicated by the fact that management have just given quite a strong warning on near-term margins haven't they?

Posted at 09/8/2021 15:11 by rivaldo
A rare event - CAR have posted some news :o))


"Carclo Technical Plastics Announces Med-Tech Innovation Attendance
27 July 2021

London (UK), 27 July 2021: Following the global pandemic and the reduction in exhibition activity, Carclo Technical Plastics (Carclo) announces that it will be exhibiting on stand no E18 at the Med-Tech Innovation Expo at the National Exhibition Centre in Birmingham, UK, now scheduled to be held 28-29 September 2021. Carclo staff will be available to discuss the use of state-of-the-art Pressure Sensing technology for optimisation, monitoring and control of the Injection Moulding process, see attached photo.

Carclo has invested significantly in advanced process monitoring equipment and personnel training/development, aimed at improving injection moulding process control and reducing costs of Quality Assurance and waste. Carclo has installed RJG’s in-mould Pressure transducers and e-Dart™ process monitoring software on its Fanuc range of all-electric injection moulding machines. Widespread use of these technologies has been made through the Process Development and Validation phases of the project, supported by existing metrology and statistical analysis using commonly available tools such as Minitab™.

Commenting, Divisional Chief Executive Officer Robert Stutzman stated “Carclo Technical Plastics has ambitious plans to continue developing our medical business, supported by Carclo’s engineering skills, global footprint and financial stability. Carclo considers the Med-Tech Innovation Expo as a key part of our annual marketing activities and we invite all customers and prospective customers to meet with us during this show.”

Carclo Technical Plastics is a contract manufacturer which specialises in injection moulding and assembly of thermoplastic components and devices for the medical, diagnostics, electronics, optics and automotive safety markets. With ISO13485-accredited production facilities in Eastern and Western USA, UK, Czech Republic, China and India, Carclo offers its global footprint to customers in these dynamic markets. Carclo’s clients range from globally-located divisions of major healthcare corporations to start-up companies who are developing products for the innovative yet highly-regulated medical industry. Typical products include medical and surgical disposables; drug delivery devices; diagnostic reagent packs; diagnostic components and devices; and ophthalmic equipment, lenses and optical components."

Carclo share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230605 16:20:36